
Sign up to save your podcasts
Or


Cliff Stocks, founder and CEO of OncoResponse speaks with BioBoss host John Simboli. Hear Cliff’s insights about leadership in biopharma and how OncoResponse is working to identify fully human monoclonal antibodies as therapeutics for the treatment of cancer.
By John Simboli5
77 ratings
Cliff Stocks, founder and CEO of OncoResponse speaks with BioBoss host John Simboli. Hear Cliff’s insights about leadership in biopharma and how OncoResponse is working to identify fully human monoclonal antibodies as therapeutics for the treatment of cancer.

3,067 Listeners

1,943 Listeners

1,093 Listeners

2,364 Listeners

949 Listeners

795 Listeners

123 Listeners

321 Listeners

6,071 Listeners

94 Listeners

10,008 Listeners

519 Listeners

146 Listeners

249 Listeners

180 Listeners